根据您提供的文献内容，我将提取相关信息并按照您指定的JSON格式进行组织。以下是提取和标准化后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "DJ-1",
            "variants": [
                {
                    "HGVS": "NM_022319.2:c.29T>C",
                    "cDNA Change": {
                        "transcript": "NM_022319.2",
                        "ref": "T",
                        "alt": "C",
                        "position": "29"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "10"
                    },
                    "Description in input context": "c.29T>C (p.L10P)"
                },
                {
                    "HGVS": "NM_022319.2:c.472delC",
                    "cDNA Change": {
                        "transcript": "NM_022319.2",
                        "ref": "C",
                        "alt": "-",
                        "position": "472"
                    },
                    "Protein Change": {
                        "ref": "P",
                        "alt": "-",
                        "position": "158"
                    },
                    "Description in input context": "c.472delC (p.P158del)"
                },
                {
                    "HGVS": "NM_022319.2:c.496C>T",
                    "cDNA Change": {
                        "transcript": "NM_022319.2",
                        "ref": "C",
                        "alt": "T",
                        "position": "496"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "166"
                    },
                    "Description in input context": "c.496C>T (p.L166P)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005071"
    },
    "Experiment Method": [
        {
            "Assay Method": "Pulse-chase protein turnover analysis",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "CHO",
                "Description": "CHO cells were transfected with pZeoSV2 full-length WT, L10P, L166P, or P158DEL human DJ-1 constructs."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_022319.2:c.29T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L10P DJ-1 exhibited reduced stability and was significantly destabilized compared to WT DJ-1."
                },
                {
                    "Variant": "NM_022319.2:c.472delC",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "P158DEL DJ-1 exhibited reduced stability and was significantly destabilized compared to WT DJ-1."
                },
                {
                    "Variant": "NM_022319.2:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L166P DJ-1 exhibited reduced stability and was significantly destabilized compared to WT DJ-1."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in triplicates."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Two-way ANOVA and Bonferroni’s post hoc test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein stability comparable to WT DJ-1.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein stability significantly reduced compared to WT DJ-1.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Co-immunoprecipitation and heterodimer or homodimer analysis",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "CHO",
                "Description": "CHO cells were co-transfected with N-terminal HA-tagged full-length WT human DJ-1 construct and pZeoSV2 full-length untagged WT, L10P, L166P, or P158DEL human DJ-1 constructs."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_022319.2:c.29T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "L10P DJ-1 retained the ability to dimerize with WT DJ-1 but was unable to form homodimers."
                },
                {
                    "Variant": "NM_022319.2:c.472delC",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "P158DEL DJ-1 retained the ability to dimerize with WT DJ-1 but was unable to form homodimers."
                },
                {
                    "Variant": "NM_022319.2:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L166P DJ-1 was not co-immunoprecipitated with HA-tagged WT DJ-1 and was unable to form homodimers."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in triplicates."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Proper dimerization with WT DJ-1 and homodimer formation.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Impaired dimerization with WT DJ-1 and inability to form homodimers.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Size Exclusion Chromatography",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "CHO",
                "Description": "CHO cells were transfected with full-length WT, L10P, L166P, or P158DEL human DJ-1 pZeoSV2 (+) constructs."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_022319.2:c.29T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "L10P DJ-1 exhibited an apparent elution profile consistent with a slightly larger conformation than WT protein, despite the finding that it cannot homodimize."
                },
                {
                    "Variant": "NM_022319.2:c.472delC",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "P158DEL DJ-1 exhibited an elution profile indicating that it is natively smaller than WT protein, suggesting that it may be predominantly monomeric."
                },
                {
                    "Variant": "NM_022319.2:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L166P DJ-1 formed high-molecular-weight complexes and was deficient in the ability to form homodimers."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were repeated at least 3 times."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Elution profile consistent with dimer formation.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Elution profile indicating altered structural conformations.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Protein solubility and biochemical fractionation",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "CHO",
                "Description": "CHO cells were transfected with full-length WT, L10P, L166P, or P158DEL human DJ-1 pZeoSV2 (+) constructs."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_022319.2:c.29T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "L10P DJ-1 demonstrated reduced solubilities, particularly evident following treatments with MG-132 or epoxomicin."
                },
                {
                    "Variant": "NM_022319.2:c.472delC",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "P158DEL DJ-1 demonstrated reduced solubilities under native conditions, but proteasome inhibition did not enhance the accumulation of insoluble species."
                },
                {
                    "Variant": "NM_022319.2:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L166P DJ-1 demonstrated dramatic accumulations of insoluble proteins following treatments with MG-132 or epoxomicin."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in triplicates."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein solubility comparable to WT DJ-1.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Reduced solubility and accumulation of insoluble proteins.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Co-immunofluorescence analysis",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "CHO",
                "Description": "CHO cells were transfected with full-length WT, L10P, L166P, or P158DEL human DJ-1 pZeoSV2 (+) constructs."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_022319.2:c.29T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "L10P DJ-1 formed intracellular inclusions following proteasome inhibition, particularly evident in 84±13% of cells treated with MG-132."
                },
                {
                    "Variant": "NM_022319.2:c.472delC",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "P158DEL DJ-1 formed intracellular inclusions following proteasome inhibition, particularly evident in 68±11% of cells treated with MG-132."
                },
                {
                    "Variant": "NM_022319.2:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L166P DJ-1 formed intracellular inclusions following proteasome inhibition, particularly evident in 49±10% of cells treated with MG-132."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in triplicates."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Two-way ANOVA and Bonferroni’s post hoc test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "No intracellular inclusions.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Formation of intracellular inclusions.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cell viability studies",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "CHO",
                "Description": "CHO cells stably expressing WT or L10P DJ-1 were generated."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_022319.2:c.29T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "L10P DJ-1 was unable to rescue CHO cells under proteasome stress conditions and was toxic, leading to significantly reduced viabilities."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in triplicates."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "1"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Two-way ANOVA and Bonferroni’s post hoc test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Viability comparable to WT DJ-1.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Significantly reduced viabilities.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明

1. **变异信息提取**：从文献中提取了DJ-1基因的三个变异（L10P、P158DEL 和 L166P），包括它们的HGVS命名、cDNA变化和蛋白质变化，并通过API进行了标准化。

2. **疾病描述**：确定文献研究的疾病为帕金森病（Parkinson disease），并通过MONDO数据库获取了对应的术语（MONDO:0005071）。

3. **实验方法及详细信息**：列出了文献中提到的所有实验方法（如脉冲追踪蛋白周转分析、共免疫沉淀、尺寸排阻色谱、蛋白质溶解性和生化分级分离、共免疫荧光分析、细胞活力研究），并提取了每种方法的材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法以及正常和异常结果的阈值。

4. **实验方法是否常用**：根据文献内容和常识判断，这些实验方法是常用的用于研究帕金森病的方法。

以上信息已严格按照您提供的JSON格式进行组织，并确保信息准确和符合科学文献标准。如果有任何进一步的需求或修改，请告知。